David Kénizou
David Kénizou publishes mostly in Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery, on topics such as Atrial Fibrillation Management and Outcomes, Cardiac Arrhythmias and Treatments and Cardiac electrophysiology and arrhythmias.
- World rank
- #2,847,083 of 7,710,434 ranked researchers
- Rank in France
- #120,897 of 324,115
- Works
- 23
- Citations
- 606
- Citations per work
- 26.3
What does David Kénizou research?
David Kénizou's work is mostly in Medicine (85%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2085.3%
- Medicine2085.3%
- Everything else314.7%
- 1Cardiology and Cardiovascular Medicine57% of their works
- 2Pulmonary and Respiratory Medicine12% of their works
- 3Surgery6% of their works
- 4Radiology, Nuclear Medicine and Imaging4% of their works
- 5Epidemiology3% of their works
- 6Hematology3% of their works
Research topics
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
- Heart Failure Treatment and Management
- Cardiac pacing and defibrillation studies
- Cardiac Imaging and Diagnostics
- Blood Pressure and Hypertension Studies
- Electrolyte and hormonal disorders
Which keywords describe David Kénizou's research?
The keywords of their largest research topics: Catheter Ablation, Arrhythmias, Guidelines, Sudden Cardiac Death, Anticoagulant Therapy, Atrial Fibrillation, Heart Failure and Radiofrequency Ablation.
- Hyponatremia
- Blood Pressure
- Coronary Artery Disease
- Cardiac Imaging
- B-Type Natriuretic Peptide
- Cardiovascular Disease
- Ion Channels
- Radiofrequency Ablation
- Atrial Fibrillation
- Sudden Cardiac Death
- Arrhythmias
- Catheter Ablation
- Guidelines
- Anticoagulant Therapy
- Heart Failure
- Ventricular Tachycardia
- Long-QT Syndrome
- Diagnosis
- Epidemiology
- Cardiac Resynchronization Therapy
- Implantable Cardioverter-Defibrillator
- Hypertension
- Vasopressin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Catheter Ablation172 topics
- Arrhythmias152 topics
- Guidelines132 topics
- Sudden Cardiac Death102 topics
- Anticoagulant Therapy91 topic
- Atrial Fibrillation91 topic
- Heart Failure93 topics
- Radiofrequency Ablation81 topic
- Ventricular Tachycardia81 topic
- Ion Channels71 topic
- Long-QT Syndrome71 topic
- Cardiovascular Disease62 topics
- Diagnosis62 topics
- B-Type Natriuretic Peptide41 topic
- Epidemiology41 topic
- Cardiac Imaging31 topic
- Cardiac Resynchronization Therapy31 topic
- Coronary Artery Disease31 topic
- Implantable Cardioverter-Defibrillator31 topic
- Blood Pressure21 topic
- Hypertension21 topic
- Hyponatremia21 topic
- Vasopressin21 topic
Where does David Kénizou work?
David Kénizou's main affiliation in the publication record is Centre Hospitalier de Mulhouse, France.
How many publications and citations does David Kénizou have?
OpenAlex counts 23 works and 606 citations for David Kénizou, an h-index of 7, ranking #2,847,083 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David Kénizou. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.